AstraZeneca PLC
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Net debt: $26,912M in Q2 2026, up 6.7% from a year earlier. That is the highest of the 23 quarters on record here.
Latest, Q2 2026
26,912
Period ended Jun 30, 2026
Change on a year earlier
+6.7%
25,227 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below
Where the Q2 2026 figure comes from
“|| Net debt | (26,912) | (23,374) | (25,227)”
Source: Form 6-K FY2026Q2 Earnings Release ↗
Reported in Form 6-K Quarterly & Form 20-F Net Debt Reconciliation Table.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up net debt
Cite this data
StockData. (2026). AstraZeneca Net debt ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/nd-net-debt
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.